Dizal Announces Positive Pooled Data of Sunvozertinib in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Published in Lung Cancer

Dizal Announces Positive Pooled Data of Sunvozertinib in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Published in Lung Cancer

Sunvozertinib, as a single agent, demonstrated promising antitumor activity and favorable safety profile in heavily pretreated patients with EGFR-mutated NSCLC who had developed resistance to EGFR TKI treatment SHANGHAI, Dec. 11, 2024 /PRNewswire/...

NEW REPORT HIGHLIGHTS PATHWAYS TO A SUSTAINABLE FUTURE FOR THE FOOD AND BEVERAGE INDUSTRY

NEW REPORT HIGHLIGHTS PATHWAYS TO A SUSTAINABLE FUTURE FOR THE FOOD AND BEVERAGE INDUSTRY

OSLO, Norway, Dec. 9, 2024 /PRNewswire/ -- DNV, the independent assurance and risk management provider, published a new report highlighting the urgent need for the food and beverage sector to transform its supply chains to meet sustainability...

Asian banks play a critical role in empowering consumers as part of their sustainability agenda, according to Fair Finance Asia

Asian banks play a critical role in empowering consumers as part of their sustainability agenda, according to Fair Finance Asia

PHNOM PENH, Cambodia, Dec. 5, 2024 /PRNewswire/ -- Fair Finance Asia (FFA) has published a new scorecard assessing to what extent Asian banks enable consumers to actively contribute to sustainability outcomes. Fair Finance Asia (2024, December)....

Initiative shows how youth can create a better digital world

Initiative shows how youth can create a better digital world

BEIJING, Nov. 27, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn: The Global Youth Leaders Initiative was published at the 2024 World Internet Conference (WIC) Wuzhen Summit on Nov 21, 2024. [Photo/chinadaily.com.cn] The Global Youth...

Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology

Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology

ROCKVILLE, Md. and SUZHOU, China, Nov. 22, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for...

BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series

BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series

New seven-part series explores disparities in care, funding and innovation impacting half the world's population LONDON, Nov. 21, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative...

Research Team of Shandong University Reveals Global Overconsumption Driving Earth Breach Safe Boundaries

Research Team of Shandong University Reveals Global Overconsumption Driving Earth Breach Safe Boundaries

JINAN, China, Nov. 21, 2024 /PRNewswire/ -- Recently, the Weihai Institute for Interdisciplinary Research team of Shandong University, in collaboration with multiple research teams both domestically and internationally, has made advancements in...

  • 1
  • 2
  • menu
    menu